# Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lenalidomide-induces-complete-and-partial-remissions-in-patients-with-relapsed/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alessandra Ferrajoli,Bang-Ning Lee,Ellen Schlette,Susan O’Brien,Hui Gao,Sijin Wen,William G. Wierda,Zeev Estrov,Stefan Faderl,Evan N. Cohen,Changping Li,James M. Reuben,Michael J. Keating |
| Citations | 399 |
| DOI | 10.1182/blood-2007-12-130120 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ashpublications.org/blood/article-pdf/111/11/5291/1294937/zh801108005291.pdf |
| OpenAlex ID | https://openalex.org/W2012721290 |
| PMID | 18334676 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Sijin Wen](https://scholariq.org/researchers/sijin-wen/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Paper topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.